Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

NCT03348059 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis c

Interventions

DRUG: Direct-acting antiviral therapy

Sponsor

Hospices Civils de Lyon